NCT06117306 - MDMA-assisted Massed Prolonged Exposure for PTSD | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2026

Conditions

Post-Traumatic Stress Disorder

Interventions

DRUG

3,4 Methylenedioxymethamphetamine

1 MDMA session

BEHAVIORAL

Prolonged Exposure

12 90-minute PE sessions; initial two sessions both occurring during the first treatment visit, third and fourth sessions occurring during the MDMA session, and the remaining sessions occurring daily or every other day

Trial Locations (1)

92161

RECRUITING

VA San Diego Healthcare System, San Diego, CA, San Diego